BeyondSpring, Inc.BeyondSpring, Inc.BeyondSpring, Inc.

BeyondSpring, Inc.

No trades
See on Supercharts

BYSI fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in Florham Park, NJ.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
BYSI has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company